Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platform

por Chen, Yu, Zhang, Xu-Chao, Yan, Wen-Qing, Guo, Wei-Bang, Xie, Zhi, Lu, Dan-Xia, Lv, Zhi-Yi, Chen, Zhi-Hong, Su, Jian
Publicado 2020

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients

por Tian, Hong‐xia, Chen, Zhi‐hong, Jie, Guang‐Ling, Wang, Zhen, Yan, Hong‐hong, Wu, Si‐pei, Zhang, Shui‐lian, Lu, Dan‐xia, Zhang, Xu‐chao, Wu, Yi‐long
Publicado 2022

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma

por Yin, Kai, Feng, Hui‐Bo, Li, Lin‐Lin, Chen, Yu, Xie, Zhi, Lv, Zhi‐Yi, Guo, Wei‐Bang, Lu, Dan‐Xia, Yang, Xue‐Ning, Yan, Wen‐Qing, Wu, Yi‐Long, Zhang, Xu‐Chao
Publicado 2019

An integrated biomarker of PD‐L1 expression and intraepithelial CD8 (+) T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection o...

por Li, Lin‐Lin, Zhou, De‐Xiang, Lu, Ming, Zhou, Dong, Lin, Xiao‐Feng, Chen, Yu, Yin, Kai, Feng, Hui‐Bo, Guo, Wei‐Bang, Xie, Zhi, Yan, Wen‐Qing, Lv, Zhi‐Yi, Lu, Dan‐Xia, Zhang, Shui‐Lian, Zhang, Xu‐Chao
Publicado 2022

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer

por Zhang, Shi-Ling, Zhang, Chan-Yuan, Chen, Yu-Qing, Li, Yu-Fa, Xie, Zhi, Zhang, Xu-Chao, Zhou, Qing, Zhong, Wen-Zhao, Huang, Jie, Sun, Hao, Zheng, Ming-Ying, Xiao, Fa-Man, Yan, Hong-Hong, Lu, Dan-Xia, Lv, Zhi-Yi, Wu, Yi-Long, Chen, Hua-Jun, Yang, Jin-Ji
Publicado 2023

High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

por Feng, Hui‐Bo, Chen, Yu, Xie, Zhi, Jiang, Jie, Zhong, Yu‐Min, Guo, Wei‐Bang, Yan, Wen‐Qing, Lv, Zhi‐Yi, Lu, Dan‐Xia, Liang, Hong‐Ling, Xu, Fang‐Ping, Yang, Jin‐Ji, Yang, Xue‐Ning, Zhou, Qing, Zhang, Dong‐Kun, Zhang, Zhou, Chuai, Shao‐Kun, Zhang, Heng‐Hui, Wu, Yi‐Long, Zhang, Xu‐Chao
Publicado 2021

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma

por Zhong, Yu-Min, Yin, Kai, Chen, Yu, Xie, Zhi, Lv, Zhi-Yi, Yang, Jin-Ji, Yang, Xue-Ning, Zhou, Qing, Wang, Bin-Chao, Zhong, Wen-Zhao, Gao, Ling-Ling, Zhou, Wen-Bin, Chen, Ji, Tu, Hai-Yan, Liao, Ri-Qiang, Zhang, Dong-Kun, Zhang, Shui-Lian, Lu, Dan-Xia, Zheng, Hong-Bo, Zhang, Heng-Hui, Wu, Yi-Long, Zhang, Xu-Chao
Publicado 2022